Brief: Abeona Therapeutics Inc Says Joseph Vazzano Has Been Appointed Chief Financial Officer
31/03/2022 12:39
March 31 (Reuters) - Abeona Therapeutics Inc ABEO.O :
* ABEONA THERAPEUTICS INC SAYS JOSEPH VAZZANO HAS BEEN
APPOINTED
CHIEF FINANCIAL OFFICER
* ABEONA THERAPEUTICS INC - QTRLY BASIC AND DILUTED LOSS PER
COMMON SHARE $0.45
Source text for Eikon: ID:nGNX1HLbn7
Further company coverage: ABEO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary